NSAIDS Flashcards

1
Q

Immune response is the body’s way to defend itself
from invading bacteria, fungi, viruses, and nonliving substances that appear foreign and harmful
(toxins, chemicals, drugs, and foreign particles.

A

INFLAMMATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Steps in the process of inflammation

A
  1. Histamine and prostaglandin release
  2. capillaries dilate clotting begins
  3. chemotactic factors attract phagocytic cells
  4. Phagocytes consume pathogens and cell debris
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

5 cardinal signs of inflammation

A
  1. Pain (Dolor)
  2. Heat (Calor)
  3. Redness (Rubor)
  4. Swelling (Tumor)
  5. Loss of function (functio laesa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

is an abnormally high temperature
associated with infection and is triggered by the release of prostaglandins.

A

FEVER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Steps in the process of fever

A
  1. Pathogens activate leukocytes
  2. Leukocytes relese cytokines
  3. Cytokines stimulate hypothalamus
  4. Hypothalamus release Prostaglandin
  5. Prostaglandins trigger fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Enzyme that is Responsible for the synthesis of Prostaglandins
(PGs)

A

CYCLOOXYGENASE (COX)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mediators of pain, inflammation and fever.

A

Prostaglandins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Constitutive Enzyme
responsible for the Maintenance function

A

COX1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Constantly expressed even there are no inflammation

A

COX1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the maintenance COX1 is responsible for

A
  1. Platelet aggregation
    (TXA2)
  2. Cytoprotection
    (PGE)
  3. Vasodilation
    (PG1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ADR of NSAID when it
is overuse:

A

PUD (Peptic
Ulcer Disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Inducible Enzyme

A

COX-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

 Low at normal states
but increases during
inflammatory
processes.

A

COX- 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alternative splice
variant of COX-1

A

COX-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Potently inhibited by
Paracetamol

A

COX-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Very abundant in
CNS
(HYPOTHALAMUS)

A

COX -3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DRugs that produce Symptomatic relief
NOT ALL OTC

A

NSAIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Indications of NSAIDS

A
  1. Analgesic
  2. Antipyretic
  3. Anti-inflammatory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

TRue or false
As the dose increases in NSAIDs it will become a prescription drug (Rx)

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MECHANISM OF ACTION of NASAIDS

A

Inhibitors of COX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

EFFECTS of NSAIDS

A

Decreased Prostaglandin synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

SIDE/ADVERSE EFFECTS of NSAIDS

A
  1. GASTROINTESTINAL ULCERATION
  2. SODIUM AND WATER RETENTION
  3. Low renal vasodilation
  4. ↑Uric Acid
  5. HYPERSENSITIVITY REACTIONS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

SIDE/ADVERSE EFFECTS of NSAIDS

A
  1. GASTROINTESTINAL ULCERATION
  2. SODIUM AND WATER RETENTION
  3. Low renal vasodilation
  4. ↑Uric Acid
  5. HYPERSENSITIVITY REACTIONS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

True or false

NSAID - should be taken with
meals

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Weakly acidic in nature

A

NSAIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Risk Factors of NSAIDS

A

Risk Factors:
o Old age
o High dose NSAIDs
o Multiple NSAID therapy
o Prior history of PUD o Concurrent use of steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

true or false
NSAIDS are responsible in increase in PG-induced inhibition of renal Chloride reabsorption.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what are the drugs that contraindicated in
patients with gout.

A

ASA and Tolmetin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Non-Selective COX Inhibitors of NSAIDS

A

METHYL SALICYLATE
BISMUTH SUBSALICYLATE
ASPIRIN (ASA)

INDOMETHACIN

PIROXICAM

DICLOFENAC
SULINDAC
NABUMETONE
KETOROLAC

IBUPROFEN
NAPROXEN
TOLMETIN

PHENYLBUTAZONE
OXYPHENBUTAZONE

MEFENAMIC ACID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

NSAIDs Selective COX-2 Inhibitors

A

MELOXICAM
ETODOLAC

CELECOXIB
ETORICOXB
PARECOXIB
ROFECOXIB
VALDECOXIB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Non-Acetylated SAlicylates

A

METHYL SALICYLATE
BISMUTH SUBSALICYLATE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Acetylated Salicylates

A

ASPIRIN (ASA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Pharmacokinetics of Aspirin

A

Absorption: Absorbed in the stomach and intestines unhydrolyzed.

Distribution: Highly protein bound; hydrolysed to its active form.

Metabolism: LT 600mg/day →First order kinetics
MT 600mg/day →Zero order kinetics

Excretion: Enhanced by urinary alkalinization

32
Q

Aspirin therapeutics

A
  1. Analgesic
  2. Antipyretic
  3. Anti-inflammatory
  4. Antiplatelet
33
Q

true and false

ASPIRIN is the only drug that is
utilized as antiplatelet in high doses

A

false

34
Q

responsible for platelet aggregation that synthesized by PG

A

TXA2

35
Q

true or false

Low doses of aspirin have been found to
non-selectively inhibit the synthesis of TXA2
without having as much effect on
prostacyclin, whereas higher doses inhibit the
synthesis of both prostaglandins.

A

false

36
Q

true of false

aspirin inhibits platelet aggregation for the life of the platelet and effectively reduces platelet aggregation when administered twice a day or every other day.

A

false

37
Q

dose of aspirin that produces anti platelet effect

A

80-160 mg

38
Q

dose of aspirin that produces analgesic and antipyretic effect

A

650-975 mg

39
Q

dose of aspirin that produces salicylism

A

3-30 g

40
Q

dose of aspirin that produces anti inflammatory effect and tinnitus

A

3-6 g

41
Q

dose of aspirin that produces hyperventilation and respiratory alkalosis

A

6-10 g

42
Q

dose of aspirin that produces fever, dehydration and metabolic acidosis

A

10-20 g

43
Q

dose of aspirin that produces shock coma, respiratory and renal failure and death

A

20-30 g

44
Q

(early sign of salicylate toxicity)

A

Tinnitus 3-6 g

45
Q

(stimulation of medulla leading to
exhalation of carbon dioxide)

A

Hyperventilation

46
Q

Treatment of salicylism

A
  1. Emesis and gastric lavage to remove
    unabsorbed drug.
  2. IV NaHCO3.
  3. Administration of fluid, electrolytes, and
    supportive care.
47
Q

ADVERSE EFFECTS of ASA

A
  1. Salicylism
  2. Severe Anaphylactic Reactions
  3. Reye’s Syndrome
48
Q

adverse effect of ASA if Children is given aspirin while having viral
infection (chicken pox, flu) or recovering from it

A

Reye’s syndrome

49
Q

Reye’s syndrome manifestation

A

Hepatic failure and
Encephalopathy

50
Q

One of the most potent inhibitors of CCX isozymes.

A

INDOLE DERIVATIVE

51
Q

Non- selective CoX inhibitor that Closes the Ductus Arteriosus

A

INDOMETHACIN

52
Q

PG analog used to maintain the potency
of Ductus Arteriosus

A

ALPROSTADIL

53
Q

→ Selective COX-1 inhibitor.
→ Long half-life: 50 hours
→ Higher risk for PUD.

A

PIROXICAM

54
Q

First NSAID for parenteral use.
available also as ophthalmic solution

A

Ketorolac

55
Q

PHENYLACETIC ACID Derivatives

A

DICLOFENAC
SULINDAC
NABUMETONE
KETOROLAC

56
Q

PHENYLACETIC ACID Derivatives that used for less than 5 days only (toxic: hematologic toxicity )

A

Ketorolac

57
Q

The only non-acidic NSAID

A

NABUMETONE

58
Q

IBUPROFEN brand name

A

(Advil®, Medicol®)

59
Q

NAPROXEN brand name

A

(Skelan®, Flanax®)

60
Q

test that rapidly screen out infection
versus neoplastic disease and significantly
narrow the differential diagnoses.

A

Naproxen test

61
Q

Contraindicated in patients with gout

A

TOLMETIN

62
Q

Non- selective CoX inhibitor that Withdrawn from the market.

A

PHENYLBUTAZONE
OXYPHENBUTAZONE

63
Q

Non- selective CoX inhibitor that Withdrawn from the market.

A

PHENYLBUTAZONE
OXYPHENBUTAZONE

64
Q

MEFENAMIC ACID brand names

A

Ponstan®
Dolfenal®

65
Q

COX 2 inhibitor that is Withdrawn

A

ROFECOXIB
VALDECOXIB

66
Q

Specific COX-2 inhibitors.
Lesser risk for NSAID induced PUD

A

true

67
Q

Disadvantage of COX-2 inhibitors : chronic thrombotic events → stroke and MI

A

false - acute

68
Q

what are the most important prostaglandins affecting platelet aggregation

A

PROSTACYCLIN (also called
prostaglandin I2 [PGI2])
TXA2.

69
Q

synthesized by vascular endothelial cells and inhibits
platelet aggregation

A

Prostacyclin

70
Q

it is synthesized by platelets and promotes platelet aggregation.

A

TXA2

71
Q

Aka Acetaminophen (present in USP)

A

PARACETAMOL

72
Q

Not an NSAID
 analgesic and antipyretic activity
 weak anti-inflammatory activity

A

PARACETAMOL

73
Q

Weak peripheral inhibitor of COX at the peripheral circulation.
Inhibits COX-3

A

Paracetamol

74
Q

true or false
A minor pathway involves oxidation of acetaminophen by cytochrome P450 enzymes (CYP1A2, CYP2E1, and CYP3A isozymes) to form a potentially non-toxic intermediate, N-acetyl-pbenzoquinone imine (NAPQI).

A

false - toxic

75
Q

paracetamol toxicity result

A

hepatic necrosis.

76
Q

given to treat acetaminophen overdose protects the liver by maintaining or restoring the glutathione levels, or by acting as an alternative substrate for conjugation with and thus detoxification of the reactive

rich in SH

A

Acetylcysteine (Mucomyst)

77
Q

Acetaminophen is primarily metabolized by what

A

conjugation with sulfate and glucuronide.

78
Q

is an unpleasant sensory and emotional
experience that serves to alert an individual to actual or potential tissue damage.

A

Pain